Company: EHC
Filing Date: 2025-08-06
Form Type: 10-Q
Source: 0000785161-25-000052
Chunk: 43

Company: Encompass Health Corp
Filing Date: 2025-08-06
Form: 10-Q
Item: Part I, Item 1
Chunk 43
---
 stock in the open market(0.2)— — — (16.8)— (16.8)Other0.8 — (3.3)— 5.2 0.1 2.0 Balance at end of period100.7 $1.2 $1,806.8 $602.3 $(570.9)$642.0 $2,481.4 

The accompanying notes to condensed consolidated financial statements are an integral part of these condensed statements.5

Encompass Health Corporation and SubsidiariesCondensed Consolidated Statements of Cash Flows(Unaudited)

 Six Months Ended June 30, 20252024 (In Millions)Cash flows from operating activities:  Net income$381.4 $285.3 Loss from discontinued operations, net of tax1.4 2.5 Adjustments to reconcile net income to net cash provided by operating activities—  Depreciation and amortization159.1 143.2 Stock-based compensation23.8 22.9 Deferred tax expense5.3 4.2 Other, net1.1 14.2 Change in assets and liabilities, net of acquisitions— Accounts receivable(15.7)0.9 Other assets(16.5)(48.4)Accounts payable(2.5)1.8 Other liabilities23.3 32.3 Net cash used in operating activities of discontinued operations(1.9)(2.7)Total adjustments176.0 168.4 Net cash provided by operating activities558.8 456.2 Cash flows from investing activities:Purchases of property, equipment, and intangible assets(320.0)(296.3)Proceeds from sale of restricted investments132.0 17.0 Purchases of restricted investments(127.8)(8.2)Other, net(8.1)(0.6)Net cash used in investing activities(323.9)(288.1)Cash flows from financing activities:Principal payments on debt, including pre-payments(10.7)(2.4)Borrowings on revolving credit facility60.0 50.0 Payments on revolving credit facility(80.0)(50.0)Principal payments under finance lease obligations(11.6)(10.7)Repurchases of common stock, including fees and expenses(56.8)(16